POST LEONARD E 4
4 · CG Oncology, Inc. · Filed Jul 18, 2025
Insider Transaction Report
Form 4
POST LEONARD E
Director
Transactions
- Exercise/Conversion
Common Stock
2025-07-17$0.60/sh+2,000$1,200→ 2,000 total - Sale
Common Stock
2025-07-17$28.00/sh−2,000$56,000→ 0 total - Exercise/Conversion
Director Stock Option (right to buy)
2025-07-17−2,000→ 126,077 totalExercise: $0.60Exp: 2028-07-08→ Common Stock (2,000 underlying)
Footnotes (2)
- [F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 6, 2024.
- [F2]Fully vested